{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:54:01Z","timestamp":1791176041073,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,20]]},"DOI":"10.1097\/qad.0b013e32835b8c7f","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T04:00:40Z","timestamp":1352347240000},"page":"563-572","source":"Crossref","is-referenced-by-count":190,"title":["An internationally generalizable risk index for mortality after one year of antiretroviral therapy"],"prefix":"10.1097","volume":"27","author":[{"given":"Janet P.","family":"Tate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mocroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Nattermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona C.","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner C.","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari M.","family":"Kitahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.C.","family":"Sterne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/597468","article-title":"Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.","volume":"48","author":"Mocroft","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archinte.165.4.416","article-title":"The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.","volume":"165","author":"DArminio","year":"2005","journal-title":"Arch Intern Med"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.","volume":"338","author":"Deeks","year":"2009","journal-title":"BMJ"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11904-010-0041-9","article-title":"HIV and aging: time for a new paradigm.","volume":"7","author":"Justice","year":"2010","journal-title":"Curr HIVAIDS Rep"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection.","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/cir989","article-title":"Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV.","volume":"54","author":"Justice","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations.","volume":"113","author":"Vasan","year":"2006","journal-title":"Circulation"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/605292","article-title":"Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.","volume":"49","author":"Aberg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R13-8-20210130","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/597354","article-title":"Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database.","volume":"48","author":"Srasuebkul","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1086\/338267","article-title":"A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.","volume":"185","author":"Lundgren","year":"2002","journal-title":"J Infect Dis"},{"key":"R15-8-20210130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/135965350801300802","article-title":"Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.","volume":"13","author":"Harris","year":"2008","journal-title":"Antivir Ther"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1468-1293.2009.00757.x","article-title":"Towards a combined prognostic index for survival in HIV infection: the role of non-HIV biomarkers.","volume":"11","author":"Justice","year":"2010","journal-title":"HIV Med"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"R19-8-20210130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/oxfordjournals.aje.a115470","article-title":"National sources of vital status information: extent of coverage and possible selectivity in reporting.","volume":"131","author":"Boyle","year":"1990","journal-title":"Am J Epidemiol"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/oxfordjournals.aje.a117426","article-title":"Mortality ascertainment in the veteran population: alternatives to the National Death Index.","volume":"141","author":"Fisher","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIVHCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function: measured and estimated glomerular filtration rate.","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"R23-8-20210130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/EDE.0b013e31821b5332","article-title":"The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology.","volume":"22","author":"Kowalska","year":"2011","journal-title":"Epidemiology"},{"key":"R24-8-20210130","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R25-8-20210130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1536867X0600600302","article-title":"Confidence intervals for rank statistics: Somers D and extensions.","volume":"6","author":"Newson","year":"2006","journal-title":"Stata J"},{"key":"R26-8-20210130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction.","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"R27-8-20210130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.2011.1966","article-title":"Prognostic indices for older adults: a systematic review.","volume":"307","author":"Yourman","year":"2012","journal-title":"JAMA"},{"key":"R28-8-20210130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values.","volume":"59","author":"Donders","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"R29-8-20210130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-130-6-199903160-00016","article-title":"Assessing the generalizability of prognostic information.","volume":"130","author":"Justice","year":"1999","journal-title":"Ann Intern Med"},{"key":"R30-8-20210130","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories.","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"R32-8-20210130","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: The Framingham Study risk score functions.","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"R33-8-20210130","first-page":"118","article-title":"Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.","volume":"17","author":"Deeks","year":"2009","journal-title":"Top HIV Med"},{"key":"R34-8-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s15010-010-0079-z","article-title":"Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort.","volume":"39","author":"Leone","year":"2011","journal-title":"Infection"},{"key":"R35-8-20210130","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/590150","article-title":"Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.","volume":"47","author":"Effros","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R36-8-20210130","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e3283174636","article-title":"The role of HIV in serious diseases other than AIDS.","volume":"22","author":"Phillips","year":"2008","journal-title":"AIDS"},{"key":"R37-8-20210130","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/QAD.0b013e3282ed6338","article-title":"Risk of cancers during interrupted antiretroviral therapy in the SMART study.","volume":"21","author":"Silverberg","year":"2007","journal-title":"AIDS"},{"key":"R38-8-20210130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4 count-guided interruption of antiretroviral treatment.","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R39-8-20210130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM200102153440701","article-title":"The continuing value of the Apgar score for the assessment of newborn infants.","volume":"344","author":"Casey","year":"2001","journal-title":"N Engl J Med"},{"key":"R40-8-20210130","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2005-07-3046","article-title":"The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration.","volume":"107","author":"Beutler","year":"2006","journal-title":"Blood"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e32835b8c7f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:20:09Z","timestamp":1687785609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201302200-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835b8c7f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,20]]}}}